Cargando…
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of developing lower extremity peripheral artery disease (PAD) and suffering PAD-related morbidity and mortality. However, the effect and burden of COPD on patients with PAD is less well defined. This post ho...
Autores principales: | Galani, Jemi, Mulder, Hillary, Rockhold, Frank W, Weissler, E Hope, Baumgartner, Iris, Berger, Jeffrey S, Blomster, Juuso I, Fowkes, F Gerry R, Hiatt, William R, Katona, Brian G, Norgren, Lars, Mahaffey, Kenneth W, Quint, Jennifer K, Patel, Manesh R, Jones, W Schuyler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018572/ https://www.ncbi.nlm.nih.gov/pubmed/33824584 http://dx.doi.org/10.2147/COPD.S292978 |
Ejemplares similares
-
Understanding Study Drug Discontinuation Through EUCLID
por: Weissler, E. Hope, et al.
Publicado: (2022) -
World regional differences in outcomes for patients with peripheral
artery disease: Insights from the EUCLID trial
por: Norgren, Lars, et al.
Publicado: (2021) -
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID
por: Samsky, Marc D., et al.
Publicado: (2021) -
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial
por: Rymer, Jennifer A., et al.
Publicado: (2020) -
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease
por: Szarek, Michael, et al.
Publicado: (2022)